The Broader Significance of a New Drug for a Rare Form of ALS

(MedPage Today) -- A major milestone in the treatment of amyotrophic lateral sclerosis (ALS) occurred on April 25, 2023, when the FDA approved tofersen (Qalsody) for patients carrying the disease-causing mutation superoxide dismutase 1 (SOD1)...
Source: MedPage Today Public Health - Category: American Health Source Type: news